T3 Defense Says It Regained Nasdaq Bid-Price Compliance After 1-for-125 Reverse Split

by Adam Kowalczyk · August 18, 2026

Filings & Deals Reporter, The MicroCap Herald

T3 Defense Inc. (Nasdaq: DFNS) said on August 17, 2026 that it had regained compliance with the Nasdaq minimum bid price requirement, resolving a listing deficiency that had hung over the micro-cap company since the spring. According to the announcement, Nasdaq confirmed the company was back in compliance after its common stock closed at or above the required $1.00 per share for 10 consecutive business days from August 3 to August 14, 2026.

The requirement at issue is Nasdaq Listing Rule 5550(a)(2), the $1.00 minimum closing bid price standard that applies to companies listed on the Nasdaq Capital Market. The rule is a continued-listing condition, and a sustained shortfall can ultimately lead to delisting if a company cannot cure it within the periods Nasdaq allows.

The compliance question dated to a deficiency notice T3 Defense disclosed on May 8, 2026. In that filing, the company said Nasdaq had informed it that its shares had traded below the $1.00 threshold over a period of 30 consecutive business days, and that it had been granted 180 calendar days, until November 2, 2026, to regain compliance by stringing together 10 consecutive business days at or above $1.00.

The mechanism the company used to lift its price was a reverse stock split. In a July 16, 2026 release and a corresponding Form 8-K, T3 Defense said it would carry out a 1-for-125 reverse split effective at 12:01 a.m. Eastern Time on July 20, 2026, describing the move as intended to raise the per-share bid price above $1.00 and bring the company back into compliance with Rule 5550(a)(2).

The July materials show the split was a large one. The company said the share count would fall from roughly 139.8 million shares before the split to approximately 1 million shares afterward. The disclosures also indicate the board escalated the ratio late in the process: the company stated that, 'Given the recent stock activity, the T3 Board of Directors determined to significantly increase the ratio from the 1-for-50 disclosed on the Current Report on Form 8-K filed by the Company with the SEC.'

A reverse split changes the number of shares outstanding but not, by itself, a company's underlying value or a stockholder's proportional ownership, apart from minor adjustments arising from rounding. Fractional shares were rounded up to the nearest whole share, with no fractional shares issued and no cash paid in lieu of fractions, according to the reverse-split disclosure.

The company was explicit that the maneuver carried no guarantee of a durable result. In the reverse-split filing, T3 Defense cautioned that it 'cannot provide assurance that the Reverse Stock Split will achieve the desired effects or that, if achieved, such desired effects will be sustained.' Regaining compliance addresses the bid-price test as of mid-August, but it does not preclude the stock from slipping back below $1.00, which could reopen the deficiency.

For investors, several risk factors remain in view. A share count of roughly one million leaves the company with a very thin public float, which can amplify price swings and reduce trading liquidity. The prior expansion to nearly 140 million shares before the split points to a history of significant share issuance, and micro-cap issuers that have relied on the equity markets to fund operations often face continued dilution. The May notice itself underscored the stakes: coverage of that filing noted that a failure to cure could result in delisting unless Nasdaq granted an additional compliance period, for which the company would owe a non-refundable application fee of USD 5,000.

The compliance update arrived alongside other corporate activity. Reporting on the August filing noted that T3 Defense has described plans to invest USD 2.5 million over the coming year in a venture referred to as Project35 following the acquisition of a 60% stake, indicating the company is continuing to deploy capital even as it works through its listing standing.

The episode sits against a broader backdrop in which Nasdaq has been tightening the standards governing micro-cap listings, including changes to how bid-price compliance periods work and restrictions on the repeated use of reverse stock splits to cure deficiencies. That environment raises the bar for the smallest listed companies to remain on the exchange.

This article is a factual account of T3 Defense's regulatory filings and public statements and is not investment advice. Figures and dates are drawn from the company's disclosures and contemporaneous reporting; readers evaluating a nano-cap security of this kind should weigh the delisting, low-float, and dilution risks described above and consult the company's SEC filings directly.